| No. | Age | Gender | Mutant gene | Mutation site | Gene Mutation Status | Mutation Type | Method | Histological diagnosis | TNM | Stage (AJCC) |
| R-RLN0201 | 45 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T3N1aM0 | IIIA |
| R-RLN0202 | 71 | M | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T3N2M0 | IIIB |
| R-RLN0203 | 46 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T4N2M1 | IV |
| R-RLN0204 | 56 | M | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T2N2M0 | IIIA |
| R-RLN0205 | 39 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T2aN0M0 | IB |
| R-RLN0206 | 50 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T4N1M1 | IV |
| R-RLN0207 | 43 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T2N2M0 | IIIA |
| R-RLN0208 | 56 | M | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T2N2M0 | IIIA |
| R-RLN0209 | 34 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T1N2M0 | IIIA |
| R-RLN0210 | 49 | M | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T1N0M0 | IA |
| R-RLN0211 | 47 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T3N0M0 | IIB |
| R-RLN0212 | 53 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T1N0M0 | IA |
| R-RLN0213 | 55 | M | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T1N0M0 | IA |
| R-RLN0214 | 69 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T2N0M0 | IIA |
| R-RLN0215 | 69 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T1N0M0 | IA |
| R-RLN0216 | 55 | M | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T1N2M0 | IIIA |
| R-RLN0217 | 55 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T2N0M0 | IIA |
| R-RLN0218 | 60 | M | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T2N0M0 | IIA |
| R-RLN0219 | 55 | F | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T1N0M0 | IA |
| R-RLN0220 | 58 | M | ROS1 | ROS1 | Mutant typ | fusion | PCR | Adenocarcinoma | T3N3M1 | IV |
|